NCT00148395View on ClinicalTrials.gov

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

PHASE3CompletedINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

April 30, 2008

Conditions

Non-Small-Cell Lung Carcinoma

Interventions

DRUG

Gemcitabine

DRUG

Navelbine

DRUG

Carboplatin

DRUG

Cisplatin

DRUG

Mitomycin

DRUG

Ifosfamide

Trial Locations (1)

34125

Klinikum Kassel GmbH, Kassel

All Listed Sponsors

lead

Aktion Bronchialkarzinom e.V.

OTHER

NCT00148395 - Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. | Biotech Hunter | Biotech Hunter